Overview

Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in PD Patients With Motor Fluctuations

Status:
Enrolling by invitation

Trial end date:
2022-02-28

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the long-term safety and clinical utility of IPX203 in the treatment of subjects with advanced Parkinson's disease (PD) who have motor fluctuations.

Phase:

Phase 3

Details

Lead Sponsor:

IMPAX Laboratories, Inc.
Impax Laboratories, LLC